AirSculpt Technologies, Inc.

AirSculpt Technologies, Inc.

AIRSNYSE / NASDAQHealthcareSmall cap

$0.59-$0.06 (-9.6%)

Last close · Data as of Nov 20, 2026

Market cap
$402.8M
P/E
-34.5x
EV / EBITDA
391.4x
Revenue
$151.8M
Net margin
-7.7%
ROCE
-3.0%

This period includes a one-day price step on 6 Nov 2026 that looks like a share split or a similar corporate action. The figure is hidden until the price history is adjusted for it.

AirSculpt Technologies, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
Hidden
3M
Hidden
6M
Hidden
1Y
Hidden
5Y
Hidden
  • This period includes a one-day price step on 6 Nov 2026 that looks like a share split or a similar corporate action. The figure is hidden until the price history is adjusted for it.

52-week range

This period includes a one-day price step on 6 Nov 2026 that looks like a share split or a similar corporate action. The figure is hidden until the price history is adjusted for it.

Day change -$0.06 (-9.6%) from $0.65 to $0.59 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in AIRS, bought on each weekday since 2021.

News & filings

What AirSculpt Technologies filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernThe company made a net loss of 11.7 million US dollars in fiscal 2025.

Strengths

No strength stands out for this company on the data on file.

  • This period includes a one-day price step on 6 Nov 2026 that looks like a share split or a similar corporate action. The figure is hidden until the price history is adjusted for it.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure.

Read moreShow less

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.

Sector
Healthcare
Shares outstanding
64.5M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$402.8M
P/E
-34.5x
P/B
4.6x
EV / EBITDA
391.4x
EV / Sales
3.1x
P/S
2.7x
52-week high
Hidden
52-week low
Hidden

Profitability

Operating margin
-3.2%
Net margin
-7.7%
EBITDA margin
0.8%
ROE
-13.3%
ROCE
-3.0%
ROIC
-5.6%
ROA
-6.2%
Asset turnover
0.81

Growth

Revenue
$151.8M
Revenue growth, 1Y
-15.8%
Revenue CAGR, 3Y
-3.5%
Net profit growth, 1Y
45.5%
Free cash flow
$692.0k

Solvency

Current ratio
0.55
Debt / Equity
0.95
Debt / Assets
0.45
CFO / Net profit
-0.27
Cash / Market cap
2.1%

Where the revenue went

FY2025 ended in a loss, so the lines are listed rather than drawn as a flow.

LineFY2025
Revenue$151.8M
Cost of revenue$61.7M
Gross profit$90.1M
Operating expenses$95.0M
Selling, general and administrative$82.2M
Operating income-$4.8M
Interest and other-$12.8M
Pretax income-$17.6M
Tax and other-$6.0M
Net income-$11.7M

Revenue and net profit

Revenue fell 15.8% in FY2025; net profit is the dashed line.

AirSculpt Technologies, Inc. revenue and net profit by fiscal year
AirSculpt Technologies, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$168.8M-$14.7M
FY2023$195.9M-$4.2M
FY2024$180.3M-$8.0M
FY2025$151.8M-$11.7M

Cash flows

FY2025: $3.1M from operations, $692.0k free after investment (dashed).

AirSculpt Technologies, Inc. operating and free cash flow by fiscal year
AirSculpt Technologies, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$24.4M$11.5M
FY2023$24.0M$14.0M
FY2024$11.3M-$2.7M
FY2025$3.1M$692.0k

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$151.8M-15.8%1Y
EBITDA
$1.2M-88.2%1Y
Net profit
-$11.7M
Cash from operations
$3.1M-72.7%1Y
Free cash flow
$692.0k
Revenue CAGR, 3Y
-3.5%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$151.8M$1.2M-$11.7M$692.0k-13.3%-15.8%+45.5%

Monthly returns

Month-by-month returns of AIRS across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$187.3M
Liabilities$99.6M
Equity$87.7M
Paid-in capital$128.3M
Retained earnings-$40.6M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; AIRS highlighted.

P/E against peers

Most of this group is loss-making, so EV / Sales is compared for the companies without a P/E.

EV / Sales, for the companies without earnings

  1. AirSculpt Technologies, Inc. (this company)3.1x

Not shown (no positive earnings and no EV / Sales): Monopar Therapeutics Inc., Compass Therapeutics, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
AirSculpt Technologies, Inc.AIRSthis company$402.8M-34.5x4.6x-13.3%391.4x
Orthofix Medical Inc.OFIX$418.0M-4.5x0.9x-20.5%51.8x
Cross Country Healthcare, Inc.CCRN$409.0M-4.3x1.3x-29.4%-4.7x
Upstream Bio, Inc.UPB$404.3M-2.8x1.2x-42.2%-1.9x
Monopar Therapeutics Inc.MNPR$399.3M-29.1x2.9x-10.0%-20.2x
Community Health Systems, Inc.CYH$393.2M0.8x-0.3x-36.5%5.5x
TruBridge, Inc.TBRG$390.7M89.7x2.2x2.4%12.5x
OmniAb, Inc.OABI$385.6M-6.0x1.4x-24.3%-8.1x
Compass Therapeutics, Inc.CMPX$383.6M-5.8x1.9x-33.8%-5.1x
Peer median—-4.4x1.4x-26.8%-3.3x

Year-to-date ROI

AIRS since 1 January, against earlier years.

Historical volatility

AIRS's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

AirSculpt Technologies, Inc. operating margin by fiscal year
AirSculpt Technologies, Inc. operating margin by fiscal year
DateOperating margin
FY2022-2.1%
FY20234.9%
FY2024-0.9%
FY2025-3.2%
LineFY2025
Cost of revenueCost Of Revenue$61.7M
Gross profitGross Profit$90.1M
Operating expensesOperating Expense$95.0M
Selling, general and administrativeSelling General And Administration$82.2M
Depreciation and amortisationDepreciation And Amortization In Income Statement$12.8M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$12.8M
Total expensesTotal Expenses$156.7M
Pretax incomePretax Income-$17.6M

Learn while you research

Academy chapters picked for AirSculpt Technologies, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  3. 03 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  4. 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  5. 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →